Trial Profile
A retrospective study of rosuvastatin assessing Efficacy and safety in late-onset hypogonadism patients with dyslipidaemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Dyslipidaemias; Hypogonadism
- Focus Therapeutic Use
- 04 Nov 2015 New trial record